STOCK TITAN

Enovis to Host Third Quarter 2022 Conference Call on November 2nd

(Neutral)
(Neutral)
Tags
conferences earnings

Rhea-AI Summary

Enovis Corporation (NYSE: ENOV) will host an investor conference call and live webcast on November 2, 2022, at 8:00 AM ET to discuss its Q3 2022 financial results. An earnings press release will precede the call. Investors can access the live webcast through the Enovis website, and for participation, U.S. callers can dial (800) 715-9871, while international callers should use (646) 307-1963 with conference ID 1914045. A replay will also be available later on the website. Enovis focuses on innovative medical solutions for improved patient outcomes.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – ENOV

+2.80%
+2.80% Session move

In the trading session that priced this news, ENOV gained 2.80%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google


Wilmington, DE, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its third quarter 2022 financial results on Wednesday, November 2, 2022 at 8:00AM ET and issue an earnings press release earlier that morning. A presentation related to the call will be available on www.enovis.com in the “Investors” section.

Conference call/Webcast Information

Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (800) 715-9871 (U.S. callers) and (646) 307-1963 (International callers) and provide the conference ID 1914045. A link to a replay of the call will also be available on the Enovis website later that day.

ABOUT ENOVIS

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.

Derek Leckow
Vice President, Investor Relations
Enovis Corporation
+1-302-421-1971
investorrelations@enovis.com

Source: Enovis Corporation


FAQ

When will Enovis Corporation discuss its Q3 2022 financial results?

Enovis Corporation will discuss its Q3 2022 financial results on November 2, 2022, at 8:00 AM ET.

How can I access the Enovis investor conference call?

You can access the Enovis investor conference call by visiting their website for the live webcast or by calling (800) 715-9871 for U.S. callers and (646) 307-1963 for international callers.

What is the conference ID for the Enovis conference call?

The conference ID for the Enovis conference call is 1914045.

Will there be a replay of the Enovis conference call?

Yes, a replay of the Enovis conference call will be available on their website later that day.

Where can I find the earnings press release from Enovis?

The earnings press release from Enovis will be issued on their website earlier on November 2, 2022, before the conference call.